Leveraging Big Data to Transform Drug Discovery
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-9089-4_6
Reference82 articles.
1. Eder J, Sedrani R, Wiesmann C (2014) The discovery of first-in-class drugs: origins and evolution. Nat Rev Drug Discov 13(8):577–587
2. Mullard A (2016) Parsing clinical success rates. Nat Rev Drug Discov 15(7):447
3. Every-Palmer S, Howick J (2014) How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract 20(6):908–914
4. Rothwell PM (2006) Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 1(1):e9
5. Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking;Science Advances;2024-08-30
2. Large language model aided automatic high-throughput drug screening using self-controlled cohort study;2024-08-05
3. Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework;PLOS ONE;2024-03-22
4. In Silico Methods Used in Drug Repurposing;Drug Repurposing;2024
5. Development of digital health management systems in longitudinal study: The Malaysian cohort experience;DIGITAL HEALTH;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3